CD28 within cancer cells also enhances PD-L1 expression by stabilizing CD274 mRNA through its interaction with SNRPB2, driving immune evasion in triple-negative breast cancer (28). The gene discussed is SNRPB2; the disease is triple-negative breast carcinoma.